Predict your next investment

Corporate Venture
ventures.mckesson.com

See what CB Insights has to offer

Investments

43

Portfolio Exits

11

Funds

1

Service Providers

1

About McKesson Ventures

McKesson Ventures is a strategic venture capital fund, to invest in early and growth stage companies addressing both current and emerging business challenges facing the healthcare industry. McKesson Ventures is actively making minority investments in companies that span a broad section of healthcare. The fund is focused on helping build businesses that are driving towards a stronger, more sustainable future for healthcare and will target companies that are both enabling and benefitting from the disruptive changes affecting the industry. These changes include increasing consumerism, emergence of alternate delivery models and the shift towards value based reimbursement models. These target companies will predominantly be pursuing high growth opportunities adjacent to or outside McKesson's current business.

McKesson Ventures Headquarter Location

1 Post Street

San Francisco, California, 94104,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing McKesson Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find McKesson Ventures in 3 Expert Collections, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

P

Pharma Supply Chain

19 items

P

Pharma Supply Chain in Healthcare Tech Market Map

19 items

Latest McKesson Ventures News

Global Tele pharmacy Market (2021 to 2026) - Featuring Pipeline Health Holdings, McKesson Ventures and MedTel Services Among Others

Sep 23, 2021

Key factors, such as rising awareness about the tele pharmacy, improving medication administration, and advancing digital technology will help in the growth of the market. Moreover, the growing number of internet users and rising internet penetration is also boosting the market growth. Operational and technical issues associated with host IT system, integration along with lack of overall management in dispensing medications for the patients, and prevalence of insufficiently skilled pharmacist are the restraining factors of tele pharmacy market. Privacy issues and operational & technical issues associated with host IT system and integration are the major challenge to the growth of this market. Recent Developments 1. One Touch Telehealth announces its new software release, Version 5.0: 'Beyond Virtual Care.' Carrie Chitsey, Co-Founder and CEO says that, 'With the increase in video telehealth amid COVID-19, virtual care is here to stay. We fast-tracked our new release given the 500%+ increase in the use of video telehealth from our client base and insights from our customers on what they need to be successful in virtual patient workflows.' - 10th November 2020 2. Pipeline Health agrees to $ 1.5 Mn settlement over Illinois hospital acquisition - 28th July 2020 3. Pipeline Acquires Business Unit from Health Enterprises to Provide Tele pharmacy Services in Iowa and Nebraska and Establishes Long-term Partnership. - 10th August 2017 Company Profiles Some of the companies covered in this report are Pipeline Health Holdings., Medication Review, Inc., North West TelePharmacy Solutions, McKesson Ventures, Pipeline Health Holdings, Mitsui & Co., Inc., MedTel Services, TelePharm, LLC, One Touch Telehealth, Comprehensive Pharmacy Services, Inc., and Telepharmacy Solutions, Inc. Competitive Quadrant The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report? The report offers a comprehensive evaluation of the Global Telepharmacy Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report. The report also contains the competitive analysis using Competitive Quadrants, the analyst's proprietary competitive positioning tool. Report Highlights: Important market dynamics and trends Market segmentation

McKesson Ventures Investments

43 Investments

McKesson Ventures has made 43 investments. Their latest investment was in Tact.ai as part of their Series E on September 9, 2021.

CBI Logo

McKesson Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/20/2021

Series E

Tact.ai

$33M

Yes

dRx Capital, Eli Lilly and Company, M12, and Salesforce Ventures

2

8/24/2021

Series B

AllStripes

$50M

Yes

Arif Nathoo, Jazz Venture Partners, Leila Rastegar Zegna, Lux Capital, Maveron, Medidata Solutions, and Spark Capital

5

3/22/2021

Series E

Evidation

$153M

No

B Capital Group, Kaiser Permanente Ventures, and OMERS Private Equity

4

3/17/2021

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/20/2021

8/24/2021

3/22/2021

3/17/2021

1/7/2021

Round

Series E

Series B

Series E

Private Equity

Series B

Company

Tact.ai

AllStripes

Evidation

Subscribe to see more

Subscribe to see more

Amount

$33M

$50M

$153M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

dRx Capital, Eli Lilly and Company, M12, and Salesforce Ventures

Arif Nathoo, Jazz Venture Partners, Leila Rastegar Zegna, Lux Capital, Maveron, Medidata Solutions, and Spark Capital

B Capital Group, Kaiser Permanente Ventures, and OMERS Private Equity

Sources

2

5

4

10

10

McKesson Ventures Portfolio Exits

11 Portfolio Exits

McKesson Ventures has 11 portfolio exits. Their latest portfolio exit was Augmedix on October 06, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/6/2020

Reverse Merger

Malo Holdings Corp

1

9/21/2020

Acquired

$991

Illumina

18

8/1/2020

Acquired

Undisclosed Investors

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

10/6/2020

9/21/2020

8/1/2020

00/00/0000

00/00/0000

Exit

Reverse Merger

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Malo Holdings Corp

Illumina

Undisclosed Investors

Subscribe to see more

Subscribe to see more

Sources

1

18

1

10

10

McKesson Ventures Fund History

1 Fund History

McKesson Ventures has 1 fund, including McKesson Ventures.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/10/2014

McKesson Ventures

1

Closing Date

12/10/2014

Fund

McKesson Ventures

Fund Type

Status

Amount

Sources

1

McKesson Ventures Service Providers

1 Service Provider

McKesson Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

McKesson Ventures Team

2 Team Members

McKesson Ventures has 2 team members, including current Managing Director, Tom Rodgers.

Name

Work History

Title

Status

Tom Rodgers

Advanced Technology Ventures

Managing Director

Current

Dave Schulte

Managing Director

Current

Name

Tom Rodgers

Dave Schulte

Work History

Advanced Technology Ventures

Title

Managing Director

Managing Director

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.